Shah Sujal has been a registered insider since 2003.
As Chief Executive Officer at CymaBay Therapeutics Inc., Shah Sujal last made a transaction on 3/13/2024.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 11 |
55% |
35% |
10% |
377 |
1 Year |
11 |
0% |
-- |
-- |
-- |
| 11 |
36% |
16% |
-19% |
356 |
9 Month |
11 |
0% |
-- |
-- |
-- |
| 11 |
55% |
-5% |
8% |
147 |
6 Month |
11 |
0% |
-- |
-- |
-- |
| 11 |
45% |
-1% |
-1% |
147 |
3 Month |
11 |
0% |
-- |
-- |
-- |
| 11 |
64% |
13% |
11% |
93 |
1 Month |
11 |
0% |
-- |
-- |
-- |
| 12 |
58% |
2% |
3% |
33 |
1 Week |
12 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| -- |
-- |
-- |
-- |
-- |
1 Year |
-- |
-- |
-- |
-- |
-- |
| -- |
-- |
-- |
-- |
-- |
9 Month |
-- |
-- |
-- |
-- |
-- |
| -- |
-- |
-- |
-- |
-- |
6 Month |
-- |
-- |
-- |
-- |
-- |
| 3 |
0% |
72% |
71% |
29 |
3 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
0% |
15% |
14% |
22 |
1 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
0% |
5% |
5% |
10 |
1 Week |
3 |
0% |
-- |
-- |
-- |
| Scorecards Updated 12/18/2024 08:23 AM EST |
Latest Transaction Date: |
3/13/2024 |
| Average days between Transaction and Entered Dates: |
2 |
